Name: Global Osteoporosis Drugs Market Research Report | Size, Share & Growth Insights, Industry Latest Trends and Future Forecast to 2033
Creator: IMARC Group
License: https://www.imarcgroup.com/privacy-policy
Keywords: Osteoporosis Drugs Market Report

Osteoporosis Drugs Market Report by Product Type (Bisphosphonates, Calcitonin, Rank Ligand Inhibitor, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, and Others), Route of Administration (Oral, Injectable, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3104

Buy Now

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Osteoporosis Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Bisphosphonates
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Calcitonin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Rank Ligand Inhibitor
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Parathyroid Hormone Therapy (PTH)
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Selective Estrogen Receptor Modulators (SERMs)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Sclerostin Inhibitor
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Injectable
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Amgen Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Eli Lilly and Company
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 F. Hoffmann-La Roche AG
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 SWOT Analysis
13.3.4 GlaxoSmithKline Plc
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Merck & Co. Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Novartis AG
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Pfizer Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Radius Health Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 Teva Pharmaceutical Industries Ltd.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 UCB S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Osteoporosis Drugs Market: Major Drivers and Challenges
Figure 2: Global: Osteoporosis Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Osteoporosis Drugs Market: Breakup by Product Type (in %), 2024
Figure 4: Global: Osteoporosis Drugs Market: Breakup by Route of Administration (in %), 2024
Figure 5: Global: Osteoporosis Drugs Market: Breakup by Region (in %), 2024
Figure 6: Global: Osteoporosis Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: Global: Osteoporosis Drugs (Bisphosphonates) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Osteoporosis Drugs (Bisphosphonates) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Osteoporosis Drugs (Calcitonin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Osteoporosis Drugs (Calcitonin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Osteoporosis Drugs (Rank Ligand Inhibitor) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Osteoporosis Drugs (Rank Ligand Inhibitor) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Osteoporosis Drugs (Parathyroid Hormone Therapy- PTH) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Osteoporosis Drugs (Parathyroid Hormone Therapy- PTH) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Osteoporosis Drugs (Selective Estrogen Receptor Modulators- SERMs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Osteoporosis Drugs (Selective Estrogen Receptor Modulators- SERMs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Osteoporosis Drugs (Sclerostin Inhibitor) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Osteoporosis Drugs (Sclerostin Inhibitor) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Osteoporosis Drugs (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Osteoporosis Drugs (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Osteoporosis Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Osteoporosis Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Osteoporosis Drugs (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Osteoporosis Drugs (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Osteoporosis Drugs (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Osteoporosis Drugs (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: North America: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: North America: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: United States: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: United States: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Canada: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Canada: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Asia-Pacific: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Asia-Pacific: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: China: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: China: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Japan: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Japan: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: India: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: India: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: South Korea: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: South Korea: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Australia: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Australia: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Indonesia: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Indonesia: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Others: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Europe: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Europe: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Germany: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Germany: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: France: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: France: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: United Kingdom: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: United Kingdom: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Italy: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Italy: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Spain: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Spain: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Russia: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Russia: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Others: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Latin America: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Latin America: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Brazil: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Brazil: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Mexico: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Mexico: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Others: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Middle East and Africa: Osteoporosis Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Middle East and Africa: Osteoporosis Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Middle East and Africa: Osteoporosis Drugs Market: Breakup by Country (in %), 2024
Figure 76: Global: Osteoporosis Drugs Industry: SWOT Analysis
Figure 77: Global: Osteoporosis Drugs Industry: Value Chain Analysis
Figure 78: Global: Osteoporosis Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Osteoporosis Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Osteoporosis Drugs Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 3: Global: Osteoporosis Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 4: Global: Osteoporosis Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Osteoporosis Drugs Market: Competitive Structure
Table 6: Global: Osteoporosis Drugs Market: Key Players

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.